{"id":"W4376132330","doi":"10.1182/bloodadvances.2023009748","title":"<i>FLT3-ITD</i> does not predict inferior prognosis in acute myeloid leukemia patients aged ≥60 years","year":2023,"lang":"en","type":"letter","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Cancer Institute; Genentech; Servier; Astellas Pharma; Sierra Oncology; Incyte; Boston Pharmaceuticals; bluebird bio; Bristol-Myers Squibb; Foghorn Therapeutics; Jazz Pharmaceuticals; Gilead Sciences; Amgen; Pfizer; Agios Pharmaceuticals; GlaxoSmithKline","keywords":"Myeloid leukemia; Medicine; Internal medicine; Leukemia; Oncology; Myeloid","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0004730571,0.0009309368,0.00163922,0.001059471,0.0001382018,0.0001279827,0.0009461648,0.001330988,0.0001410559],"category_scores_gemma":[0.0006957585,0.0007365629,0.0004145391,0.001250961,0.0004059403,0.0004988679,0.0005690698,0.004985511,0.0005009444],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001049191,"about_ca_system_score_gemma":0.001322418,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002356304,"about_ca_topic_score_gemma":0.000173756,"domain_scores_codex":[0.9931315,0.0002739469,0.00117785,0.001580786,0.002120959,0.001714922],"domain_scores_gemma":[0.997318,0.0005903599,0.0004700107,0.001034291,0.0002789966,0.0003082888],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006275757,0.0003960099,0.2585019,0.002306285,0.001328053,0.0254211,0.0005594122,0.0000114546,0.001431082,0.000001709864,0.6938188,0.01559661],"study_design_scores_gemma":[0.01059982,0.001332136,0.2690208,0.00219538,0.001231652,0.00008798172,0.0000786155,0.00003087553,0.0058528,0.00007983737,0.7081763,0.001313876],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"commentary","genre_scores_codex":[0.8622044,0.001088222,0.000004339764,0.1246601,0.002242459,0.005389147,0.00196016,0.001092245,0.001358916],"genre_scores_gemma":[0.1119928,0.03002264,0.007775602,0.6922666,0.02585717,0.008921556,0.01747863,0.002820816,0.1028642],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.7502117,"threshold_uncertainty_score":0.9999655,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0136208859755537,"score_gpt":0.2750904126672631,"score_spread":0.2614695266917094,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}